Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will the AI-based ROBO1 CAR T cell immunotherapy for glioblastoma succeed in Phase I trials by end of 2024?  | Binary | 2 | 5 months ago | ||
Will the AI-based ROBO1 CAR T cell therapy for glioblastoma receive FDA approval by end of 2025? | Binary | 2 | 5 months ago | ||
Will a peer-reviewed study show significant survival benefit from AI-based ROBO1 CAR T cell therapy for glioblastoma by mid-2025? | Binary | 2 | 5 months ago | ||
What will be the next major milestone for AI-based ROBO1 CAR T cell therapy for glioblastoma by end of 2024? | Categorical | 2 | 5 months ago | ||
Which institution will lead the next phase of clinical trials for AI-based ROBO1 CAR T cell therapy for glioblastoma by Q1 2025? | Categorical | 2 | 5 months ago | ||
Which type of brain cancer will show significant response to AI-based ROBO1 CAR T cell therapy by end of 2024? | Categorical | 2 | 5 months ago |